bupropion has been researched along with Morbid Obesity in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aylwin, S | 1 |
| Al-Zaman, Y | 1 |
2 reviews available for bupropion and Morbid Obesity
| Article | Year |
|---|---|
Naltrexone/bupropion for obesity.
Topics: Anti-Obesity Agents; Bupropion; Chemotherapy, Adjuvant; Drug Combinations; Humans; Naltrexone; Obesi | 2017 |
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria | 2008 |